Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Feb;17(1):49-59.
doi: 10.1111/j.1369-7625.2011.00732.x. Epub 2011 Oct 28.

Feasibility and acceptability of a decision aid designed for people facing advanced or terminal illness: a pilot randomized trial

Dan D Matlock  1 , Tarah A E Keech, Marlene B McKenzie, Michael R Bronsert, Carolyn T Nowels, Jean S Kutner
Affiliations
Randomized Controlled Trial

Feasibility and acceptability of a decision aid designed for people facing advanced or terminal illness: a pilot randomized trial

Dan D Matlock et al. Health Expect. 2014 Feb.

Abstract

Background: Patients nearing the end of their lives face an array of difficult decisions.

Objective: This study was designed to assess the feasibility and acceptability of a decision aid (DA) designed for patients facing advanced or terminal illness.

Design: We conducted a pilot randomized clinical trial of Health Dialog's Looking Ahead: choices for medical care when you're seriously ill DA (booklet and DVD) applied to patients on a hospital-based palliative care (PC) service.

Setting: University of Colorado Hospital - December 2009 and May 2010.

Participants: All adult, English-speaking patients or their decision makers were potentially eligible. Patients were not approached if they were in isolation, did not speak English or if any provider felt that they were not appropriate because of issues such as family conflict or actively dying.

Intervention: All participants received a standard PC consultation. Participants in the intervention arm also received a copy of the DA. Measurements Primary outcomes included decision conflict and knowledge. Participants in the intervention arm also completed an acceptability questionnaire and qualitative exit interviews.

Results: Of the 239 patients or decision makers, 51(21%) enrolled in the trial. The DA had no significant effect on decision conflict or knowledge. Exit interviews indicated it was acceptable and empowering, although they wished they had access to the DA earlier.

Conclusions: While the DA was acceptable, feasibility was limited by late-life illness challenges. Future trials of this DA should be performed on patients earlier in their illness trajectory and should include additional outcome measures such as self-efficacy and confidence.

Keywords: decision aid; end-of-life; palliative care; randomized trial.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Consort diagram showing the assessment, randomization and follow‐up of study patients.
See this image and copyright information in PMC

References

    1. Sudore RL, Fried TR. Redefining theplanning in advance care planning: preparing for end‐of‐life decision making. Annals of Internal Medicine, 2010; 153: 256–261. - PMC - PubMed
    1. Goldstein NE, Back AL, Morrison RS. Titrating guidance: a model to guide physicians in assisting patients and family members who are facing complex decisions. Archives of Internal Medicine, 2008; 168: 1733–1739. - PMC - PubMed
    1. Apatira L, Boyd EA, Malvar G et al. Hope, truth, and preparing for death: perspectives of surrogate decision makers. Annals of Internal Medicine, 2008; 149: 861–868. - PMC - PubMed
    1. Fried TR, O’Leary JR. Using the experiences of bereaved caregivers to inform patient‐ and caregiver‐centered advance care planning. Journal of General Internal Medicine, 2008; 23: 1602–1607. - PMC - PubMed
    1. Singer PA, Martin DK, Kelner M. Quality end‐of‐life care. The Journal of the American Medical Association, 1999; 281: 163–168. - PubMed

Publication types